Inhibition of Coxsackievirus B3 Replication by Small Interfering RNAs Requires Perfect Sequence Match in the Central Region of the Viral Positive Strand

Coxsackievirus B3 (CVB3) is the most common causal agent of viral myocarditis, but existing drug therapies are of limited value. Application of small interfering RNA (siRNA) in knockdown of gene expression is an emerging technology in antiviral gene therapy. To investigate whether RNA interference (...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Virol
Päätekijät:	Yuan, Ji, Cheung, Paul K. M., Zhang, Huifang M., Chau, David, Yang, Decheng
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2005
Aiheet:	Vaccines and Antiviral Agents
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC546545/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15681418/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.79.4.2151-2159.2005
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!